bpc-157 clinical trial august 2025 – Research Peptide BPC157 drives angiogenesis through FBXO22-dependent

Larazotide reached Phase 3 in celiac disease, further than most research peptides, but its strongest positive result was a single mid-stage endpoint that the pivotal trial failed to confirm

Methylcobalamin is the naturally occurring, "active" form the body uses directly at the cellular level

In short, giving B12 to special groups needs a careful plan

But what if you could enhance its effects even further

Co-exposure of cardiomyocytes to IFN- and TNF- Induces mitochondrial dysfunction and nitro-oxidative stress: implications for the pathogenesis of chronic chagas disease cardiomyopathy

A man who was protesting outside of an abortion clinic asked a woman if she knew what went on inside of the clinic